Mechanism of Bone Mineralization

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2018 Apr 4

PMID 29610149

Citations 82

Authors

Monzur Murshed

Affiliations

Soon will be listed here.

Abstract

Mineralized "hard" tissues of the skeleton possess unique biomechanical properties to support the body weight and movement and act as a source of essential minerals required for critical body functions. For a long time, extracellular matrix (ECM) mineralization in the vertebrate skeleton was considered as a passive process. However, the explosion of genetic studies during the past decades has established that this process is essentially controlled by multiple genetic pathways. These pathways regulate the homeostasis of ionic calcium and inorganic phosphate-two mineral components required for bone mineral formation, the synthesis of mineral scaffolding ECM, and the maintainence of the levels of the inhibitory organic and inorganic molecules controlling the process of mineral crystal formation and its growth. More recently, intracellular enzyme regulators of skeletal tissue mineralization have been identified. The current review will discuss the key determinants of ECM mineralization in bone and propose a unified model explaining this process.

Citing Articles

A 7T MRI Study of Fibular Bone Thickness and Density: Impact of Age, Sex and Body Weight, and Correlation with Bone Marrow Expansion and Muscle Fat Infiltration.

Johnson T, Su J, Henning A, Ren J Diagnostics (Basel). 2025; 15(5).

PMID: 40075811 PMC: 11899192. DOI: 10.3390/diagnostics15050564.

The Preventive Impact of Chokeberry ( L.) Extract Regarding the Disruption of Calcium and Phosphorus Homeostasis and Chosen Pathways of Its Regulation in an Animal Model of General Population Exposure to Cadmium.

Brzoska M, Galazyn-Sidorczuk M, Rogalska J Nutrients. 2025; 17(4).

PMID: 40005030 PMC: 11858106. DOI: 10.3390/nu17040702.

Amorphous calcium phosphate-coated surfaces as a model for bone microenvironment in prostate cancer.

San Martin R, Das P, Xue T, Brown M, Dos Reis Marques R, Essington M Heliyon. 2025; 11(3):e41929.

PMID: 39931470 PMC: 11808503. DOI: 10.1016/j.heliyon.2025.e41929.

Understanding the structural biology of osteomalacia through multiscale 3D X-ray and electron tomographic imaging: a review of X-linked hypophosphatemia, the mouse model, and imaging methods.

Buss D, Deering J, Reznikov N, McKee M JBMR Plus. 2025; 9(2):ziae176.

PMID: 39896117 PMC: 11783288. DOI: 10.1093/jbmrpl/ziae176.

Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder.

Liu Q, Xue Y, Guo J, Tao L, Zhu Y Front Endocrinol (Lausanne). 2025; 15:1512398.

PMID: 39886032 PMC: 11779597. DOI: 10.3389/fendo.2024.1512398.

References

Stoffel W, Jenke B, Block B, Zumbansen M, Koebke J . Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc Natl Acad Sci U S A. 2005; 102(12):4554-9. PMC: 555473. DOI: 10.1073/pnas.0406380102. View

Eicher E, SOUTHARD J, Scriver C, Glorieux F . Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A. 1976; 73(12):4667-71. PMC: 431589. DOI: 10.1073/pnas.73.12.4667. View

Toroian D, Lim J, Price P . The size exclusion characteristics of type I collagen: implications for the role of noncollagenous bone constituents in mineralization. J Biol Chem. 2007; 282(31):22437-47. DOI: 10.1074/jbc.M700591200. View

Grynpas M, BONAR L, Glimcher M . Failure to detect an amorphous calcium-phosphate solid phase in bone mineral: a radial distribution function study. Calcif Tissue Int. 1984; 36(3):291-301. DOI: 10.1007/BF02405333. View

Hessle L, Johnson K, Anderson H, Narisawa S, Sali A, Goding J . Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A. 2002; 99(14):9445-9. PMC: 123160. DOI: 10.1073/pnas.142063399. View

Becker A, Ziegler A, Epple M . The mineral phase in the cuticles of two species of Crustacea consists of magnesium calcite, amorphous calcium carbonate, and amorphous calcium phosphate. Dalton Trans. 2005; (10):1814-20. DOI: 10.1039/b412062k. View

Macrae V, Davey M, McTeir L, Narisawa S, Yadav M, Millan J . Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick. Bone. 2010; 46(4):1146-55. PMC: 2842458. DOI: 10.1016/j.bone.2009.12.018. View

Mahamid J, Aichmayer B, Shimoni E, Ziblat R, Li C, Siegel S . Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci U S A. 2010; 107(14):6316-21. PMC: 2851957. DOI: 10.1073/pnas.0914218107. View

Masuyama R, Nakaya Y, Tanaka S, Tsurukami H, Nakamura T, Watanabe S . Dietary phosphorus restriction reverses the impaired bone mineralization in vitamin D receptor knockout mice. Endocrinology. 2001; 142(1):494-7. DOI: 10.1210/endo.142.1.8050. View

10.

Boskey A . Amorphous calcium phosphate: the contention of bone. J Dent Res. 1997; 76(8):1433-6. DOI: 10.1177/00220345970760080501. View

11.

Khavandgar Z, Murshed M . Sphingolipid metabolism and its role in the skeletal tissues. Cell Mol Life Sci. 2014; 72(5):959-69. PMC: 11114007. DOI: 10.1007/s00018-014-1778-x. View

12.

Rey C, Combes C, Drouet C, Glimcher M . Bone mineral: update on chemical composition and structure. Osteoporos Int. 2009; 20(6):1013-21. PMC: 2760485. DOI: 10.1007/s00198-009-0860-y. View

13.

Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka H, Schinke T . ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 2004; 117(3):387-98. DOI: 10.1016/s0092-8674(04)00344-7. View

14.

Eanes E, Gillessen I, Posner A . Intermediate states in the precipitation of hydroxyapatite. Nature. 1965; 208(5008):365-7. DOI: 10.1038/208365a0. View

15.

BACHRA B, Fischer H . Mineral deposition in collagen in vitro. Calcif Tissue Res. 1968; 2(4):343-52. DOI: 10.1007/BF02279222. View

16.

Mebarek S, Abousalham A, Magne D, Do L, Bandorowicz-Pikula J, Pikula S . Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations. Int J Mol Sci. 2013; 14(3):5036-129. PMC: 3634480. DOI: 10.3390/ijms14035036. View

17.

Li J, Manickam G, Ray S, Oh C, Yasuda H, Moffatt P . Smpd3 Expression in both Chondrocytes and Osteoblasts Is Required for Normal Endochondral Bone Development. Mol Cell Biol. 2016; 36(17):2282-99. PMC: 4985927. DOI: 10.1128/MCB.01077-15. View

18.

Yadav M, Simao A, Narisawa S, Huesa C, McKee M, Farquharson C . Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res. 2010; 26(2):286-97. PMC: 3179344. DOI: 10.1002/jbmr.195. View

19.

Ho A, Johnson M, Kingsley D . Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000; 289(5477):265-70. DOI: 10.1126/science.289.5477.265. View

20.

BONAR L, Roufosse A, Sabine W, Grynpas M, Glimcher M . X-ray diffraction studies of the crystallinity of bone mineral in newly synthesized and density fractionated bone. Calcif Tissue Int. 1983; 35(2):202-9. DOI: 10.1007/BF02405032. View